サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411616

避妊薬市場：製品別、年齢層別、投与経路別、流通別-2024-2030年の世界予測

Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
避妊薬市場：製品別、年齢層別、投与経路別、流通別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

避妊薬市場規模は2023年に195億3,000万米ドルと推計され、2024年には207億6,000万米ドルに達し、CAGR 6.46%で2030年には302億7,000万米ドルに達すると予測されます。

避妊薬の世界市場

主な市場の統計
基準年[2023］ 195億3,000万米ドル
予測年[2024］ 207億6,000万米ドル
予測年 [2030] 302億7,000万米ドル
CAGR（%） 6.46%
避妊薬 Market-IMG1

避妊薬は、女性の月経周期を調整し、意図しない妊娠を防ぐように設計された合成ホルモンを含む経口薬です。これらの医薬品は主に、排卵を抑制し、子宮頸管粘液を変化させて精子の通過を制限し、子宮内膜を変化させて受精卵の着床を最小限に抑えることで機能します。さまざまな年齢層や文化圏で家族計画法に対する意識が高まり、安全で効果的な避妊薬に対する需要が高まっています。しかし、市場には代替避妊法や標準以下の製品が存在するため、消費者による避妊薬の利用は制限されています。とはいえ、有効性が向上し副作用の少ない新しい製剤の開拓は、避妊薬市場に潜在的な機会をもたらすと期待されています。

地域別インサイト

南北アメリカでは、啓発キャンペーンや政府支援、メーカーによる新しい避妊薬組成の技術進歩が広まり、避妊薬市場が拡大しています。米国国立医学図書館（NLM）によると、米国では現在15～44歳の女性の約25％が避妊方法としてピルを選択しています。欧州地域では、家族計画教育を推進する公衆衛生プログラムと手頃な価格が、避妊薬の使用に人気を博しています。アジア太平洋地域は、中国やインドのような人口の多い経済圏に直面し、手頃な価格の避妊薬に対する需要を生み出し、市場の成長見通しを示しています。さらに、多くの新興諸国や発展途上国は、家族計画教育・啓発プログラムの導入を通じて、市場に好機的な展望を生み出しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは避妊薬市場を評価する上で極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、避妊薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-避妊薬市場の市場規模および予測は？

2-避妊薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-避妊薬市場における技術動向と規制の枠組みは？

4-避妊薬市場における主要ベンダーの市場シェアは？

5-避妊薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 予期せぬ妊娠を防ぐために避妊薬の使用を増やす
      • 性感染症（STD）の蔓延と意識の高まり
      • 避妊薬の使用を促進する政府の支援的取り組み
    • 抑制要因
      • 避妊薬による健康への悪影響
    • 機会
      • 避妊薬の処方と包装における継続的な進歩
      • オンラインチャネルでの避妊薬の利用可能性
    • 課題
      • 錠剤の使用に関する安全性と社会的懸念、および製品マーケティングの問題
  • 市場セグメンテーション分析
    • 製品：家族計画のための合剤の大幅な採用
    • 年齢層：15～24歳の年齢層で避妊薬の使用率が高い
    • 配布：避妊薬のオンライン配布チャネルの進化
    • 管理ルート：使いやすさによる口頭避妊薬のユーザー設定
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 避妊薬市場：製品別

  • コンビネーションピル
  • 継続/延長ピル
  • プロゲステロン錠剤

第7章 避妊薬市場：年齢層別

  • 15-24
  • 25-34
  • 35-44
  • 45歳以上

第8章 避妊薬市場：投与経路別

  • オーラル
  • ビジナル

第9章 避妊薬市場配信別

  • オフライン
  • オンライン

第10章 南北アメリカの避妊薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の避妊薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの避妊薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AbbVie Inc.
    • Afaxys Pharma, LLC
    • Amneal Pharmaceuticals, Inc.
    • Apotex Inc.
    • Aurobindo Pharma Limited
    • Bayer AG
    • Bionpharma Inc.
    • Cipla Limited
    • Combe Incorporated
    • Gedeon Richter PLC
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson Services, Inc.
    • Julie Product Inc.
    • Lupin Limited
    • Mankind Pharma Ltd.
    • Mayne Pharma Group Limited
    • Merck & Co., Inc.
    • Northstar Rx LLC
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Sun Pharmaceutical Industries Limited
    • Syzygy Healthcare Solutions, LLC
    • Teva Pharmaceuticals
    • Viatris Inc.
    • Xiromed, LLC
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
  • FIGURE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 10. CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. CONTRACEPTIVE PILLS MARKET LICENSE & PRICING
目次
Product Code: MRR-A579C4315A26

[182 Pages Report] The Contraceptive Pills Market size was estimated at USD 19.53 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 6.46% to reach USD 30.27 billion by 2030.

Global Contraceptive Pills Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.53 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 30.27 billion
CAGR (%) 6.46%
Contraceptive Pills Market - IMG1

Contraceptive pills are oral medications that contain synthetic hormones designed to regulate a woman's menstrual cycle and prevent unintended pregnancy. These pharmaceutical products primarily function by inhibiting ovulation, altering the cervical mucus to restrict sperm passage, and modifying the endometrial lining to minimize implantation of a fertilized egg. The growing awareness about family planning methods among different age groups and cultures has increase the demand for safe and effective contraceptives. However, the presence of alternative contraceptive methods or substandard products in the market limits consumers' utilization of contraceptive pills. Nevertheless, developing new formulations that offer improved efficacy and fewer side effects is expected to create potential opportunities for the contraceptive pills market.

Regional Insights

In the Americas region, the contraceptive pills market is growing owing to widespread awareness campaigns, government support, and technological advancements from manufacturers for new contraceptive pill composition. According to the National Library of Medicine (NLM), Approximately 25% of women in the U.S. aged 15-44 currently use contraception pills as their method of choice. In the European region, public health programs promoting family planning education and affordable prices have gained popularity for the use of contraceptive pills. The Asia Pacific region showcases growth prospects for the market in the face of larger population economies such as China & India, creating demand for affordable contraceptive pills. Further, many emerging & developing countries create an opportunistic landscape for the market through the adoption of family planning education & awareness programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Combination Pill
    • Continuous/Extended Pill
    • Progesterone Pill
  • Age Group
    • 15-24
    • 25-34
    • 35-44
    • 45 and Above
  • Route of Administration
    • Oral
    • Viginal
  • Distribution
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contraceptive Pills Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contraceptive Pills Market?

3. What are the technology trends and regulatory frameworks in the Contraceptive Pills Market?

4. What is the market share of the leading vendors in the Contraceptive Pills Market?

5. Which modes and strategic moves are suitable for entering the Contraceptive Pills Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Contraceptive Pills Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies
      • 5.1.1.2. Growing prevalence and awareness toward sexually transmitted diseases (STDs)
      • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
      • 5.1.3.2. Availability of contraceptive pills on online channels
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant adoption of combination pills for family planning
    • 5.2.2. Age Group: High usage of contraceptive pills in the age group 15 to 24
    • 5.2.3. Distribution: Evolving online distribution channels for contraceptive pills
    • 5.2.4. Route of Administration: User preferences for oral contraceptive pills owing to ease of use
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Contraceptive Pills Market, by Product

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Contraceptive Pills Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Viginal

9. Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. FDA approves first nonprescription daily oral contraceptive
      • 13.3.2.2. Gedeon Richter announces availability of oral contraception Drovelis

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Afaxys Pharma, LLC
    • 14.1.3. Amneal Pharmaceuticals, Inc.
    • 14.1.4. Apotex Inc.
    • 14.1.5. Aurobindo Pharma Limited
    • 14.1.6. Bayer AG
    • 14.1.7. Bionpharma Inc.
    • 14.1.8. Cipla Limited
    • 14.1.9. Combe Incorporated
    • 14.1.10. Gedeon Richter PLC
    • 14.1.11. Glenmark Pharmaceuticals Limited
    • 14.1.12. Johnson & Johnson Services, Inc.
    • 14.1.13. Julie Product Inc.
    • 14.1.14. Lupin Limited
    • 14.1.15. Mankind Pharma Ltd.
    • 14.1.16. Mayne Pharma Group Limited
    • 14.1.17. Merck & Co., Inc.
    • 14.1.18. Northstar Rx LLC
    • 14.1.19. Perrigo Company plc
    • 14.1.20. Pfizer Inc.
    • 14.1.21. Piramal Enterprises Ltd.
    • 14.1.22. Sun Pharmaceutical Industries Limited
    • 14.1.23. Syzygy Healthcare Solutions, LLC
    • 14.1.24. Teva Pharmaceuticals
    • 14.1.25. Viatris Inc.
    • 14.1.26. Xiromed, LLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing